Madrigal Pharmaceuticals has a first mover advantage in the huge MASH market due to the approval of Rezdiffra. Read whether I ...

TWO blockbuster weight loss just have been tested against each other for the first time in a head-to-head trial. There was a ...

Obesity-related cancer, a generalized term to classify specific cancer types that develop more frequently in obese patients, ...

A recent study from Bascom Palmer Eye Institute uncovered potential molecular evidence linking human papillomavirus (HPV) to ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

TH receptors are nuclear transcription factors ... investigators at the 8 th International Workshop on Resistance to Thyroid Hormone... Recent discoveries of genetic defects that reduce the ...

Researchers at Peking University have discovered that a filamentous gut fungus, Fusarium foetens, can reverse metabolic ...

Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

Terns Pharmaceuticals, Inc.’s TERN share price has surged by 11.67%, which has investors questioning if this is right time to sell.

Title: ALG-055009, a potent and selective thyroid hormone receptor beta agonist for the treatment of metabolic ...

Viking Therapeutics, Inc.’s VKTX share price has dipped by 5.22%, which has investors questioning if this is right time to buy.